Tag: metastasis

Over 1,200,000 men around the globe are diagnosed with prostate cancer (PCa) every year. They don’t all have the same disease, however. There are numerous cell lines with varying characteristics: “The disease is very heterogeneous in terms of grade, genetics, ploidy, and oncogene/tumor suppressor gene expression, and its biological, hormonal, and molecular characteristics are extremely keep reading

At the time of this writing, it’s been over a year since SARS-CoV-2, the virus that causes COVID-19, was confirmed in the U.S. Scientists around the world scrambled to unravel the mysteries of this coronavirus while millions of people around the globe have died. At this time, there are a reported 114 million active cases keep reading

Black salve. Black ointment. Bloodroot capsules. Organic bloodroot extract. Do any of these sound familiar? Have you tried any of them? Numerous preparations based on sanguinaria, or the bloodroot plant, are capturing attention due to such claims as... keep reading

It has been, and continues to be, our position that metal instruments such as a scalpel or a biopsy needle are extremely unlikely to unleash PCa tumor cells that ultimately threaten a patient’s life. The predominant opinion among clinical professionals is that, even if it were to occur, it would be exceedingly rare. Another way to come at the prostatectomy-spreading-PCa problem is to broaden the question: can surgical removal of cancer cause the cancer to spread? keep reading

More than six years ago, we published a blog post in hopes of reducing patient fears that a needle biopsy of the prostate could spread prostate cancer. Back then, we referred to occurrence of track seeding in prostate biopsies as exceedingly rare. This is what the latest research tells us today... keep reading

Good news! The widespread integration of multiparametric MRI (mpMRI) and MRI-guided targeted biopsies has resulted in both better initial qualification of AS candidates, and significantly better ability to monitor for significant PCa by PSA + mpMRI. As a side benefit... keep reading

A fictitious man named Craig was diagnosed with prostate cancer at age 64. His conventional 12-core TRUS biopsy showed he had Grade Group 2 (Gleason 3 + 4) only on the right side of his gland. Since he and his wife of 38 years, Sheila, had a good sex life, erectile function was important to keep reading

Here is fantastic news for men who undergo an initial treatment for localized prostate cancer! In November, 2020 the U.S. Food and Drug Administration (FDA) granted Fast Track Designation to RV001, an investigational vaccine against prostate cancer recurrence after primary treatment. RV001 is manufactured by a Swedish pharmaceutical company called RhoVac. Let’s look at the keep reading

If you were suddenly kidnapped and blindfolded, then abandoned in a foreign land, you would want the best possible map to get safely to the border where you could figure out a homeward-bound plan. For men who are diagnosed with high-risk prostate cancer (PCa), it’s as if a hostile unknown enemy has abducted them, deprived keep reading

Not long ago, I posted a blog on the ability of androgen deprivation therapy (ADT) to boost the effectiveness of radiation therapy for prostate cancer. This synergistic effect is very important for men with intermediate or higher risk cancer who can’t have (or don’t want) radical prostatectomy, since the greater the risk, the more likely keep reading